Drug Profile


Alternative Names: ADA; HPH-116; NSC 674447

Latest Information Update: 17 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Universite Libre de Bruxelles
  • Developer H-Phar; Universite Libre de Bruxelles
  • Class Amides; Aza compounds; Small molecules
  • Mechanism of Action HIV zinc finger inhibitors; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II HIV infections
  • No development reported Transplant rejection

Most Recent Events

  • 17 Aug 2015 Phase-II development is ongoing in Spain for HIV infections
  • 30 Aug 2011 Azodicarbonamide is still in phase II trials for HIV infection in Spain
  • 05 Sep 2007 Phase-II clinical trials in HIV infections treatment in Spain (Capsule)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top